HEADER HYDROLASE/HYDROLASE INHIBITOR 19-APR-16 5JFX TITLE CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-06273340 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 5 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 6 TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK,P140-TRKA; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21S; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRKA INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.JAYASANKAR,R.KURUMBAIL,S.SKERRATT,D.BROWN REVDAT 2 06-MAR-24 5JFX 1 REMARK REVDAT 1 01-MAR-17 5JFX 0 JRNL AUTH S.E.SKERRATT,M.ANDREWS,S.K.BAGAL,J.BILSLAND,D.BROWN, JRNL AUTH 2 P.J.BUNGAY,S.COLE,K.R.GIBSON,R.JONES,I.MORAO,A.NEDDERMAN, JRNL AUTH 3 K.OMOTO,C.ROBINSON,T.RYCKMANS,K.SKINNER,P.STUPPLE,G.WALDRON JRNL TITL THE DISCOVERY OF A POTENT, SELECTIVE, AND PERIPHERALLY JRNL TITL 2 RESTRICTED PAN-TRK INHIBITOR (PF-06273340) FOR THE TREATMENT JRNL TITL 3 OF PAIN. JRNL REF J. MED. CHEM. V. 59 10084 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27766865 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00850 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 49031 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2465 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.77 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3287 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2241 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3100 REMARK 3 BIN R VALUE (WORKING SET) : 0.2226 REMARK 3 BIN FREE R VALUE : 0.2504 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.69 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 187 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2231 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.30170 REMARK 3 B22 (A**2) : -0.30170 REMARK 3 B33 (A**2) : 0.60350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.089 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.090 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.086 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.088 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2329 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3157 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 790 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 59 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 347 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2329 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 275 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2792 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.81 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 39.8547 -6.9352 -2.8426 REMARK 3 T TENSOR REMARK 3 T11: -0.0440 T22: -0.0470 REMARK 3 T33: -0.0776 T12: -0.0083 REMARK 3 T13: 0.0144 T23: 0.0153 REMARK 3 L TENSOR REMARK 3 L11: 1.2547 L22: 0.3746 REMARK 3 L33: 1.1145 L12: 0.2532 REMARK 3 L13: 0.6196 L23: 0.3707 REMARK 3 S TENSOR REMARK 3 S11: 0.0246 S12: -0.0590 S13: -0.0107 REMARK 3 S21: -0.0123 S22: 0.0086 S23: -0.0141 REMARK 3 S31: -0.0120 S32: -0.0250 S33: -0.0331 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5JFX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220525. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51246 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 62.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.57800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CONCENTRATED TO 10MG/ML. REMARK 280 CRYSTALS OF COMPLEXES WERE GROWN USING THE HANGING DROP VAPOUR REMARK 280 DIFFUSION METHOD FROM 0.1M HEPES PH7.5, 0.1M MGCL2 AND 10% ETOH REMARK 280 AT 4C, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 15.40533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.81067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 15.40533 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 30.81067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 607 REMARK 465 ALA A 608 REMARK 465 LYS A 609 REMARK 465 LEU A 610 REMARK 465 LEU A 611 REMARK 465 ALA A 612 REMARK 465 GLY A 613 REMARK 465 GLY A 614 REMARK 465 GLU A 615 REMARK 465 ASP A 616 REMARK 465 MET A 671 REMARK 465 SER A 672 REMARK 465 ARG A 673 REMARK 465 ASP A 674 REMARK 465 ILE A 675 REMARK 465 TYR A 676 REMARK 465 SER A 677 REMARK 465 THR A 678 REMARK 465 ASP A 679 REMARK 465 TYR A 680 REMARK 465 TYR A 681 REMARK 465 ARG A 682 REMARK 465 VAL A 683 REMARK 465 GLY A 684 REMARK 465 GLY A 685 REMARK 465 ARG A 686 REMARK 465 THR A 687 REMARK 465 MET A 688 REMARK 465 VAL A 794 REMARK 465 LEU A 795 REMARK 465 GLY A 796 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 513 -69.43 -104.65 REMARK 500 ALA A 520 83.37 -64.90 REMARK 500 GLU A 548 -167.54 -112.69 REMARK 500 ALA A 549 65.20 -177.77 REMARK 500 GLU A 551 45.16 -99.66 REMARK 500 ARG A 649 -14.14 76.75 REMARK 500 ASP A 650 51.05 -143.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4401 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A4402 DISTANCE = 6.84 ANGSTROMS REMARK 525 HOH A4403 DISTANCE = 7.65 ANGSTROMS REMARK 525 HOH A4404 DISTANCE = 7.67 ANGSTROMS REMARK 525 HOH A4405 DISTANCE = 8.21 ANGSTROMS REMARK 525 HOH A4406 DISTANCE = 13.49 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6K4 A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5JFS RELATED DB: PDB REMARK 900 RELATED ID: 5JFV RELATED DB: PDB REMARK 900 RELATED ID: 5JFW RELATED DB: PDB DBREF 5JFX A 502 796 UNP P04629 NTRK1_HUMAN 404 698 SEQADV 5JFX MET A 489 UNP P04629 INITIATING METHIONINE SEQADV 5JFX HIS A 490 UNP P04629 EXPRESSION TAG SEQADV 5JFX HIS A 491 UNP P04629 EXPRESSION TAG SEQADV 5JFX HIS A 492 UNP P04629 EXPRESSION TAG SEQADV 5JFX HIS A 493 UNP P04629 EXPRESSION TAG SEQADV 5JFX HIS A 494 UNP P04629 EXPRESSION TAG SEQADV 5JFX HIS A 495 UNP P04629 EXPRESSION TAG SEQADV 5JFX LEU A 496 UNP P04629 EXPRESSION TAG SEQADV 5JFX VAL A 497 UNP P04629 EXPRESSION TAG SEQADV 5JFX PRO A 498 UNP P04629 EXPRESSION TAG SEQADV 5JFX ARG A 499 UNP P04629 EXPRESSION TAG SEQADV 5JFX GLY A 500 UNP P04629 EXPRESSION TAG SEQADV 5JFX SER A 501 UNP P04629 EXPRESSION TAG SEQRES 1 A 308 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 A 308 VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS TRP SEQRES 3 A 308 GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU ALA SEQRES 4 A 308 GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET LEU SEQRES 5 A 308 VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER ALA SEQRES 6 A 308 ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR MET SEQRES 7 A 308 LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL CYS SEQRES 8 A 308 THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR MET SEQRES 9 A 308 ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS GLY SEQRES 10 A 308 PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL ALA SEQRES 11 A 308 PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL ALA SEQRES 12 A 308 SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY LEU SEQRES 13 A 308 HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS LEU SEQRES 14 A 308 VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE GLY SEQRES 15 A 308 MET SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG VAL SEQRES 16 A 308 GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO PRO SEQRES 17 A 308 GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SER ASP SEQRES 18 A 308 VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE THR SEQRES 19 A 308 TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR GLU SEQRES 20 A 308 ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU ARG SEQRES 21 A 308 PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET ARG SEQRES 22 A 308 GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER ILE SEQRES 23 A 308 LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN ALA SEQRES 24 A 308 PRO PRO VAL TYR LEU ASP VAL LEU GLY HET 6K4 A4000 34 HETNAM 6K4 N-{5-[2-AMINO-7-(1-HYDROXY-2-METHYLPROPAN-2-YL)-7H- HETNAM 2 6K4 PYRROLO[2,3-D]PYRIMIDINE-5-CARBONYL]PYRIDIN-3-YL}-2- HETNAM 3 6K4 (5-CHLOROPYRIDIN-2-YL)ACETAMIDE FORMUL 2 6K4 C23 H22 CL N7 O3 FORMUL 3 HOH *306(H2 O) HELIX 1 AA1 HIS A 490 HIS A 494 5 5 HELIX 2 AA2 LYS A 506 ARG A 508 5 3 HELIX 3 AA3 GLU A 551 LEU A 567 1 17 HELIX 4 AA4 ASP A 596 HIS A 604 1 9 HELIX 5 AA5 GLY A 623 LEU A 644 1 22 HELIX 6 AA6 ALA A 652 ARG A 654 5 3 HELIX 7 AA7 GLN A 660 LEU A 662 5 3 HELIX 8 AA8 PRO A 690 MET A 694 5 5 HELIX 9 AA9 PRO A 695 ARG A 702 1 8 HELIX 10 AB1 THR A 705 THR A 722 1 18 HELIX 11 AB2 SER A 732 GLY A 743 1 12 HELIX 12 AB3 PRO A 753 TRP A 764 1 12 HELIX 13 AB4 GLU A 767 ARG A 771 5 5 HELIX 14 AB5 SER A 773 ALA A 787 1 15 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 GLY A 522 HIS A 530 -1 O VAL A 524 N LEU A 516 SHEET 3 AA1 5 LYS A 538 LEU A 546 -1 O VAL A 543 N PHE A 525 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 VAL A 658 0 SHEET 2 AA2 2 VAL A 664 ILE A 666 -1 O LYS A 665 N LEU A 657 CISPEP 1 SER A 550 GLU A 551 0 5.01 CISPEP 2 ARG A 583 PRO A 584 0 2.56 SITE 1 AC1 18 VAL A 524 ALA A 542 LYS A 544 LEU A 564 SITE 2 AC1 18 PHE A 589 GLU A 590 TYR A 591 MET A 592 SITE 3 AC1 18 LEU A 641 LEU A 657 ILE A 666 GLY A 667 SITE 4 AC1 18 ASP A 668 PHE A 669 HOH A4122 HOH A4132 SITE 5 AC1 18 HOH A4209 HOH A4258 CRYST1 125.013 125.013 46.216 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007999 0.004618 0.000000 0.00000 SCALE2 0.000000 0.009237 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021638 0.00000